Corvus Pharmaceuticals has developed soquelitinib, a first-in-class oral ITK inhibitor targeting moderate-to-severe atopic dermatitis and relapsed/refractory peripheral T cell lymphoma. We initiate at Buy with a 12-month price target of $40.
BuyBroadcom designs semiconductors, including custom AI chips and networking chips, and infrastructure software, selling to large cloud data centre...
BuyNetflix is the world's leading streaming entertainment service, with 301.6 million paid subscribers in more than 190 countries.Institutional...
HoldWaters Corporation is a global provider of analytical instruments, software and consumables for life sciences, pharmaceutical and industrial...
BuyITT is a US industrial manufacturer making brake pads, shock absorbers, pumps, valves and specialised connectors for vehicles, aerospace, defence...
HoldAmgen is a California biotechnology company that discovers, makes and sells medicines for cancer, heart disease, inflammation, bone health and...
BuyGenerate Biomedicines is a clinical-stage biotech that uses generative AI to design new protein medicines, with its lead program aimed at severe...
MF & Co. Asset Management is a boutique investment firm offering Equity Capital Markets and derivative general advice & trade execution services.
We are specialists in advising and trading in Australian and US Equities, Index & Equity Options and Options on Futures.
Australia
1300 889 603
International
+61 2 8378 7199
M-F: 8am-5pm
Suite 803, Level 8
70 Pitt St, Sydney, NSW 2000